Aptevo Therapeutics Inc
$ 5.03
6.12%
14 Apr - close price
- Market Cap 5,601,400 USD
- Current Price $ 5.03
- High / Low $ 5.20 / 4.75
- Stock P/E N/A
- Book Value 17.42
- EPS -87.27
- Next Earning Report 2026-05-21
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.77 %
- ROE -2.35 %
- 52 Week High 486.00
- 52 Week Low 3.80
About
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company is headquartered in Seattle, Washington.
Analyst Target Price
$21.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-01 | 2025-12-31 | 2025-11-06 | 2025-08-11 | 2025-05-15 | 2025-02-14 | 2024-11-07 | 2024-08-08 | 2024-05-08 | 2024-03-05 | 2023-11-14 | 2023-08-10 |
| Reported EPS | -5.9108 | None | -2.23 | -8.4 | -87.8 | -178.8 | -355.2 | -1.67 | -9.95 | -6.16 | -0.5 | -1.23 |
| Estimated EPS | None | -8.09 | -3.78 | -83.2 | -84.2 | -155 | -421.8 | -6.55 | -12.84 | -18.04 | -0.75 | -1.12 |
| Surprise | 0 | 0 | 1.55 | 74.8 | -3.6 | -23.8 | 66.6 | 4.88 | 2.89 | 11.88 | 0.25 | -0.11 |
| Surprise Percentage | None% | None% | 41.0053% | 89.9038% | -4.2755% | -15.3548% | 15.7895% | 74.5038% | 22.5078% | 65.8537% | 33.3333% | -9.8214% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-21 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -5.6 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
